NEW YORK (GenomeWeb News) – The University of Glasgow announced today that it has received a £3.4 million ($5.3 million) grant from the UK's Medical Research Council and the Engineering and Physical Sciences Research Council (EPSRC) to create a center for molecular diagnostics research, discovery, and development.
The so-called Molecular Pathology Node will be based at Queen Elizabeth University Hospital, and will integrate with existing initiatives including the Stratified Medicine Scotland Innovation Centre, the Precision Medicine Catapult, the Scottish Genomes Partnership, Genome England, and the International Cancer Genome Consortium.
"Our excellent training in molecular pathology, genetics, informatics, and stratified medicine will address national skill shortages and contribute to a workforce capable of developing, undertaking, interpreting, and applying the results of novel molecular diagnostics across a range of professions and expertise from geneticists, pathologists, clinical and other scientists, informaticians, and clinicians across hospital practice and primary care," University of Glasgow researcher Karin Oien said in a statement.
"The formation of these nodes will act to accelerate the development and translation of a range of molecular pathology products into the clinic and bring undoubted benefit to patients and the health service," added Jim Reid, CEO of Sistemic, a microRNA products developer and industrial partner of the new Molecular Pathology Node.